Because Alk was not differentially expressed across the three Trp53-null transplant classes, we propose that this dynamic response is due to differences in Met signaling, and, thus, spontaneous Met amplification is a driver of tumorigenesis in this mouse model of human breast cancer. Here, ALK is linked to breast cancer.